Aclarion, Inc. (ACON)
2.52
+0.13
(+5.44%)
USD |
NASDAQ |
Aug 27, 16:00
2.39
-0.13
(-5.16%)
Pre-Market: 08:59
Aclarion Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.4732 |
| March 31, 2024 | 0.2675 |
| December 31, 2023 | -1.546 |
| September 30, 2023 | -0.8786 |
| Date | Value |
|---|---|
| June 30, 2023 | 11.65 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.0021 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -0.2894 |
| December 31, 2021 | -0.3501 |
| September 30, 2021 | -0.7591 |
| June 30, 2021 | -1.019 |
| March 31, 2021 | |
| December 31, 2020 | -0.6188 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Biotricity, Inc. | -0.7993 |
| MedLink International, Inc. | -- |
| Agilent Technologies, Inc. | 0.5363 |
| Abbott Laboratories | 0.638 |
| Align Technology, Inc. | 0.0286 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 18.04M |
| Total Liabilities (Quarterly) | 1.037M |
| Shareholders Equity (Quarterly) | 17.00M |
| Current Ratio | 16.20 |